Clinical Trial Update: Evaluation of Physician Training Methods to Read Florbetapir-PET Scans [NA]

View source ↗

Summary

A completed clinical trial sponsored by Avid Radiopharmaceuticals evaluated methods for training physicians to read Florbetapir-PET scans in Alzheimer's disease…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• AMYVID (Florbetapir F-18)

Snippet

Sponsor: Avid Radiopharmaceuticals | Conditions: Alzheimer's Disease | NA | Status: COMPLETED | Results posted: 2012-06-07